Position
Fidelity in Boston Scientific Corp
Back to the book · All holders of BSX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$917.3M$62.75 → $42.68
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 97.4M | $9.29B | — | — | — | 0.5% |
| Q1 2026 | 74.2M | $4.66B | $62.75 | −$2.42B | −$2.21B | 0.2% |
| Q2 2026 | 45.7M | $1.95B | $42.68 | −$917.3M | −$1.79B | 0.1% |